running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours; not feeling well; not feeling normal; feeling tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD22-024693 (Moderna), 149362 (Moderna).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 29Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (SPIKEVAX), on 09Sep2022 as dose 5 (booster), single (Lot number: AS7140C) for covid-19 immunisation. The patient's relevant medical history included: "Sulfa" (unspecified if ongoing), notes: Allergies (medications, food and products) sulfa and cipro antibiotics and morphine.; "cipro antibiotics" (unspecified if ongoing), notes: Allergies (medications, food and products) sulfa and cipro antibiotics and morphine.; "kidney-pancreas transplant patient" (unspecified if ongoing), notes: kidney-pancreas transplant patient; "kidney-pancreas transplant patient" (unspecified if ongoing), notes: kidney-pancreas transplant patient. The patient's concomitant medications were not reported. Past drug history included: Morphine, reaction(s): "known allergy: morphine", notes: Allergies (medications, food and products) sulfa and cipro antibiotics and morphine. Vaccination history included: BNT162b2 (Dose 1, Lot number: unknown), administration date: 22Jan2021, for Covid-19 immunization, reaction(s): "running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours", "not feeling well", "not feeling normal", "feeling tired"; BNT162b2 (Dose 2, Lot number: unknown), administration date: 13Feb2021, for Covid-19 immunization, reaction(s): "running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours", "not feeling well", "not feeling normal", "feeling tired"; BNT162b2 (Dose 3, Lot number: unknown), administration date: 16Aug2021, for Covid-19 immunization, reaction(s): "running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours", "not feeling well", "not feeling normal", "feeling tired". The following information was reported: PYREXIA (non-serious), outcome "not recovered", described as "running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours"; MALAISE (non-serious), outcome "not recovered", described as "not feeling well"; FEELING ABNORMAL (non-serious), outcome "not recovered", described as "not feeling normal"; FATIGUE (non-serious), outcome "not recovered", described as "feeling tired". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, malaise, feeling abnormal, fatigue.  Additional information: Patient received her fall booster on 09Sep two weeks and 2 days ago. Patient was still running a low grade with temperatures below 100 degree F since the day after receiving the Moderna shot on 10Sep2022. Patient stated she was not feeling well, not feeling normal and feeling tired about having fever. When reading list of expected side effects with the bivalent booster caller stated that she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours. Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was Prevnar 20 pneumonia vaccination 48 hours before receiving the bivalent booster on 07Sep2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200073355 same patient, different vaccine dose/event;US-PFIZER INC-202201194742 same patient, different vaccine dose/event;